NCT02756481View on ClinicalTrials.gov

Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Non-Valvular Atrial Fibrillation
Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY